Article

The Regulation of Medical Products

Anup Malani and Tomas J. Philipson

in The Oxford Handbook of the Economics of the Biopharmaceutical Industry

Published in print April 2012 | ISBN: 9780199742998
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199742998.013.0005

Series: Oxford Handbooks

 The Regulation of Medical Products

More Like This

Show all results sharing these subjects:

  • Economics
  • Health, Education, and Welfare
  • Public Economics

GO

Show Summary Details

Preview

This article synthesizes and extends, in a nontechnical manner, recent research on the Food and Drug Administration (FDA). The aim is to shed light on whether the policies of the agency itself are safe and effective when measured in terms of economic efficiency. The first section provides an overview of the role of the FDA in regulating pharmaceutical drugs and medical devices. The second section surveys the existing efficiency rationales for government regulation of the information about and the quality of medical products, and then canvasses the literature for empirical studies on the effects of FDA regulation on innovation and costs. The final section examines the growing role of tort law—specifically, products liability litigation—in supplementing FDA regulation of drug quality.

Keywords: Food and Drug Administration; drug policy; economic efficiency; FDA regulation; medical device regulation; tort law; product liability; drug quality

Article.  17905 words. 

Subjects: Economics ; Health, Education, and Welfare ; Public Economics

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.